Status:
RECRUITING
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
Lead Sponsor:
RenJi Hospital
Conditions:
Sarcopenia
Metabolic Diseases
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to establish an ambispective cohort platform centered on the pathological axis of "sarcopenia-metabolic disorders-aging progression", integrating multimodal data including demographic ...
Detailed Description
Sarcopenia is an age-related syndrome characterized by progressive decline in skeletal muscle mass, strength, and function. Traditionally regarded as a consequence of aging, it not only impairs physic...
Eligibility Criteria
Inclusion
- Adults aged 18 and over
Exclusion
- Does not cooperate in signing the informed consent form;
- Does not possess legal capacity;
- In a state of loss of consciousness;
- Suffering from severe mental illness, unable to communicate normally;
- The researcher believes that the subject has a disease that affects the assessment of results and is unsuitable for inclusion.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2040
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT07205510
Start Date
December 1 2020
End Date
December 31 2040
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Shanghai, China